Generic Name and Formulations:
Nisoldipine 8.5mg, 17mg*, 34mg; ext-rel tabs; *contains tartrazine.
Covis Pharmaceuticals, Inc.
Indications for SULAR:
Swallow whole. Take on an empty stomach (1hr before or 2hrs after a meal). Initially 17mg once daily; may increase by 8.5mg per week or longer intervals. Usual maintenance: 17–34mg once daily; max 34mg/day. Hepatic impairment or elderly (>65yrs): Initially 8.5mg once daily.
Coronary artery disease. Heart failure or compromised ventricular function (esp. with a beta-blocker). Monitor BP closely during initiation and titration. Severe hepatic impairment. Elderly. Pregnancy (Cat.C). Nursing mothers: not recommended.
Avoid concomitant CYP3A4 inhibitors or inducers, grapefruit juice. High-fat meals increase peak drug concentrations. Antagonized by phenytoin (avoid; consider alternatives). May be potentiated by cimetidine.
Calcium channel blocker (CCB) (dihydropyridine).
Peripheral edema, headache, dizziness, pharyngitis, vasodilation, sinusitis, palpitations, chest pain, nausea, rash; increased angina, MI (rare), hypotension.
Neurology Advisor Articles
- FDA Approves Aimovig for Migraine Prevention
- Prediction Algorithm Stratifies ICH Patients at Risk for Hematoma Expansion
- Sports-Related Concussion Outcomes Predicted With Serum Neurofilament Light
- Psychological Therapies May Help Older Adults With Chronic Pain
- Traumatic Brain Injury Linked to Increased Parkinson Disease Risk in Veterans
- Amyloid Positivity Increases Risk for Cognitive Impairment in Dementia-Free Patients
- Valproic Acid-Related Adverse Fetal Outcomes May Be Linked to Placental Effects
- Risk of Dementia Up for Older Adults With Lowest Wealth
- Language Used in Medical Record Can Affect Patient Care
- Mortality in Alzheimer Disease Not Strongly Associated With Antipsychotics